Tag Archives: EAACI

Things to do in Lisbon during the 2019 EAACI Congress

The European Academy of Allergy and Clinical Immunology (EAACI) was founded  in 1956. With nearly 10,000 members from 121 countries and over 50 National Allergy Societies, the EAACI is the main source of expertise in Europe concerning all the different aspects of allergy.

 

The EAACI Annual Congress is Europe’s largest congress specialised in allergy and clinical immunology. It attracts between 7000-8000 participants and experts from all around the world. In 2019, the congress will take place between 1-5 June, in Lisbon, Portugal.

 

We’ve put together this article to give you a glimpse of what you could do while in the beautiful city of Lisbon.

 

Admire the magnificent Torre de Belém

Torre de Belém

Otherwise named “the Tower of St Vincent”, the Torre de Belém is a UNESCO World Heritage Site because of the role it played in the Portuguese maritime discoveries of the era of the Age of Discoveries. Built in the early 16th century, the tower was commissioned by King John II to be part of a defence system and a ceremonial gateway to Lisbon. The tower perfectly reflects the Portuguese Manueline style, while it also incorporates bits of other architectural styles.

 

Visit the Monastery of Jerónimos

Monastery of Jerónimos

Also as an example of the Portuguese Late Gothic Manueline style stands The Jerónimos Monastery or Hieronymites Monastery, a former monastery of the Order of Saint Jerome near the Tagus river in the parish of Belém. Built to mark Portugal’s most glorious age which was called ‘The Age of Exploration’, the monastery was classified a UNESCO World Heritage Site, along with the Tower of Belém, in 1983.

 

Tap into the city’s past at Lisboa Story Centre

Lisboa Story Centre

The museum takes visitors on a 60-minute tour through Lisbon’s history, from its early foundation (pre-ancient Roman days) to modern times. There are special sections dedicated to the Age of Exploration, including New World discoveries, as well as the terrifying 1755 earthquake and the reconstruction that followed.

 

Wonder in the natural beauty of Tróia

Troia peninsula

This will be a two-hour journey but it’s definitely worth the time. The Troia Peninsula is one of the most beautiful coastlines of Portugal, with a 13 km stretch of sands, crystal clear waters, sand dunes and pine forests. The main town is at the northern tip of the peninsula and boasts a selection of stylish restaurants and bars, and the Casino de Tróia.

 

Taste the best portuguese food at the Time Out Market

time out market

Opened in May 2014, the Time Out Market is the first market in the world where everything has been chosen, tasted and tested by an independent panel of journalists and critics. Boasting 24 restaurants, 8 bars, a dozen shops and a high-end music venue dubbed Rive Rouge, the Time Out Market is where you’re sure to find the very best food in Lisbon.

logo-congress bookers

About Congress Bookers

In the world of MICE (Meetings, Incentives, Conferences and Events), Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2019, regardless of their location. We operate internationally!

Advertisements

Top Medical Congresses to Attend in Germany in 2018

According to a new report published by Allied Market Research, the global MICE industry was valued at USD 752 billion in 2016, and is projected to reach USD 1,245 billion in 2023, registering a CAGR of 7.5% from 2017 to 2023.

In 2016, Europe dominated the global market with more than 42% market share, in terms of value. Medical events have played an important part.

In 2018, Germany will host some of the biggest medical events in Europe: EAACI 2018, ESC 2018, EASD 2018, ECTRIMS 2018, ESMO 2018.

 

The European Academy of Allergy and Clinical Immunology Annual Congress | 26-30 May

The 2018 edition will take place in Munich, Germany at the ICM – Internationales Congress Center München.

The EAACI Congress is organised by the European Academy of Allergy and Clinical Immunology (EAACI), and provides attendees with a one of a kind opportunity to learn more about the latest discoveries in the field of allergy, asthma and clinical immunology.

Munich is seen as one of the most research-focused cities in Germany. It’s well-known for important advances through R&D and innovation centres, being an environment which encourages proactive development work and close cooperation among clinics, universities and research organizations.

Book your accommodation for EAACI 2018 at one of the best hotels in Munich!

 

The 54th European Association for the Study of Diabetes Annual Meeting | 1-5 October 2018

EASD’s 2018 congress will take place in Berlin, Germany at the Messe Berlin Exhibition Halls in Berlin-Charlottenburg.

The European Association for the Study of Diabetes (EASD) was founded in 1965 as a non-profit, medical scientific association, based in Duesseldorf, Germany.

Nowadays, EASD is one of the largest networks for diabetologists worldwide with more than 5,000 active members from over 100 countries. EASD holds its Annual Meeting in a different European city each year with more than 15,000 delegates from over 130 countries attending. The scientific programme includes more than 1,200 talks and presentations on the latest results in diabetes research by leading experts in the field.

Berlin is an international city that has a long-standing tradition of more than 300 years in medical research.The city boasts extraordinary architecture, a mix of historical buildings and contemporary design. Known for its young and experimental spirit, Berlin has always been home to an active and unique art scene.

Book your accommodation for EASD 2018 at one of the best hotels in Berlin!

 

The 34th European Committee for Treatment and Research in Multiple Sclerosis Congress | 10-12 October

The 34th Congress of the ECTRIMS will take place in the bustling and lively European city of Berlin at the City Cube Messe.

As a non-profit organisation, ECTRIMS is Europe’s and the world’s largest professional organisation dedicated to the understanding and treatment of Multiple Sclerosis (MS). Its goal is to improve basic and clinical research and clinical outcomes in MS by creating a network of researchers and clinicians and partnering with other organisations that share similar missions and objectives.

Some of the topics covered in the Scientific Programme of the 2018 edition are: Treatment of relapsing and progressive MS, Risk management with MS therapies, Immunopathology of MS, Molecular imaging, and many more.

Book your accommodation for ECTRIMS 2018 at one of the best hotels in Berlin!

 

The European Society for Medical Oncology Congress | 19-23 October

The ESMO 2018 Congress will take place between 19-23 October 2018, in Munich, Germany at Messe Munich.

ESMO was founded in 1975 and is now the leading European professional organisation for medical oncology. Comprising 17,000 oncology professionals from over 150 countries, ESMO is the network of reference for oncology education and information worldwide.

The programme for the 2018 edition is available online here.

Book your accommodation for ESMO 2018 at one of the best hotels in Munich!
cb-01

About Congress Bookers

In the world of MICE (Meetings, Incentives, Conferences and Events), Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2018, regardless of their location. We operate internationally!

  • EASL 2018 – 210 rooms in seven 4-star hotels
  • EAACI 2018 – 615 rooms in fourteen 4-star hotels
  • EHA 2018 – 1200 rooms in thirty 4-star hotels
  • ERS 2018 – 615 rooms in twenty 4-star hotels
  • EURETINA 2018 – 460 rooms in twelve 4-star hotels
  • EASD 2018 – 765 rooms in sixteen 4-star hotels
  • ECTRIMS 2018 – 620 rooms in ten hotels
  • ESMO 2018 – 1092 rooms in twenty-one 4-star hotels.

Top 3 Cities For Medical Congresses in 2018

Time flies. The first half of 2017 has elapsed and we’re slowly but surely preparing for 2018. That’s the thing when you’re operating inside the MICE industry, you need to plan in advance….yes, sometimes a year in advance!

cb-01

With that in mind, we thought it would be interesting to use our website http://www.congressbookers.com/ and see where some of the biggest medical congresses will take place in 2018. You know, just in case you’re also interested in visiting some amazing cities next year while travelling for a congress.

 

Barcelona

barcelona

Home of the following big medical congresses in 2018:

If you’re in Barcelona for one of these congresses, be sure to also visit some of the city’s iconic sites.

 

Sagrada Família

The a large Roman Catholic church is designed by Antoni Gaudí. The latter dedicated more than 40 years (the last 14 of them exclusively) to the project, and is buried beneath the nave.

Construction began in 1882 and when Gaudí died in 1926 less than a quarter of the project was complete. It is hoped the masterpiece will be completed in 2026 to coincide with the 100th anniversary of Gaudí’s death.

Gaudí’s work on the building is part of a UNESCO World Heritage Site.

 

Picasso Museum

This is Barcelona’s most famous museum. The Picasso family moved to Barcelona in 1895 and Picasso lived here until 1904. You can see a unique collection of 4000 works with early sketches and canvases.

 

Vienna

Vienna

Home of the following big medical congresses in 2018:

Vienna is a city you’ll fall in love with from the first moment you set foot on its streets. Here are some things that any Vienna visitor should see (although keep in mind that the number of museums in Vienna is truly impressive!):

 

MuseumsQuartier

Designed by Fischer von Erlach, MuseumsQuartier is essentially an ensemble of museums, cafes and restaurants inside former imperial buildings. Its 60,000 sq metres of exhibition space host the Leopold Museum, MUMOK, Kunsthalle, Architekturzentrum and Zoom. The site is considered a true cultural hub.

 

Sigmund Freud Museum

Founded in 1971, the museum is actually where Freud spent his most prolific years and developed his groundbreaking theories. Freud moved here in 1891 but left in 1938 when he was forced into exile by the Nazis. The appartment was later turned into a museum by his daughter Anna.

 

Schloss Schönbrunn

From the 18th century to 1918, Schönbrunn was the residence of the Habsburg emperors. It was designed by the architects Johann Bernhard Fischer von Erlach and Nicolaus Pacassi. The palace is now a Unesco World Heritage site. Of the palace’s 1441 rooms, 40 are open to the public. Its historical importance, beautiful location and gardens make this palace one of the very top sights in Vienna.

 

Munich

munich

Home of the following big medical congresses in 2018:

An epicentre for rich culture, art and history, Munich has a museum for every interest under the sun. No matter where you are in the city, you are surrounded by its intriguing history.

 

Munich’s Residenz

The former royal palace of the Bavarian monarchs is situated in the centre of Munich and it is the largest city palace in Germany. Visitors can admire its architecture, room decorations, and displays from the former royal collections. The complex of buildings contains ten courtyards and displays 130 rooms.

 

Frauenkirche: The Cathedral of Our Dear Lady

Munich’s huge and imposing Frauenkirche was completed in 1488 as a Late Gothic church. The cathedral is 109 meters long by 40 meters wide, with high walls and sturdy twin 100-meter-tall towers. The building has a volume of about 200,000 m³ and  it is said to having had capacity to house 20,000 standing people. A rich collection of 14th to 18th century artwork of artists like Erasmus Grasser, Jan Polack, Hans Leinberger, Hans Krumpper and Ignaz Günther decorates the interior of the cathedral.

 

Are you attending a medical congress in any of these 3 big cities next year? Let us handle your accommodation needs!

Top Trends that Will Dominate the Pharma Sector in 2017

We’re soon saying goodbye to 2016, a bustling year for pharma in terms of technology, innovations, as well as mergers and acquisitions. Big companies saw important breakthroughs, new drugs have been approved by the FDA and important lawsuits have been gained. All in all, an exciting year for the pharma and healthcare industry.

pharmatrends

Now is the time to look at 2016 and understand which important trends from 2016 will pick up next year and what their influence will be.

 

Drug prices will still be heavily debated

Drug prices have made headlines over the past few years (they were even an election issue in the US) and will continue to do so throughout 2017.

Dr. Carole Bruckler, Senior Advisor at Allied World Healthcare, predicted that “2017 will be a year where ongoing trends will crystalize further,” and that  “in the US, there is clear political will forming against annual or quarterly drug price increases to fuel sales growth.”

Although a Clinton victory would have meant high drug prices, Donald Trump’s election in the US doesn’t mean that the pharma industry is out of hot water yet. His plans to have uniform pricing schemes could highly impact profit margins and may even mean a change in pharma’s existing business models.

 

Patients will hold the power

It seems that those days when patients would go to the doctor whenever they got sick to have medication prescribed are gone. Nowadays, patients are empowered. They have access to huge amounts of information online and can learn about their health conditions. When dealing with mild symptoms, they can even use the information that they find to choose from various treatment alternatives. This means that, in many instances, doctors cannot influence patients’ choices anymore. Therefore, pharma companies have to start looking for new ways to get their medications sold.

When it comes to empowered patients, pharma and healthcare companies need to understand that, thanks to technology and the opportunities it provides, their expectations are high. If they are not provided with an immediate solution, they know they always have an alternative.

Smartwatches like Apple Watch or Samsung Gear and fitness bands (FitBit, Jawbone, Garmin) have sensors capable of taking biometric readings. As they become more advanced, wearable devices will become a key asset in gathering clinical trial data remotely in real-time but also in helping patients monitor their health without the need for a doctor or nurse.

 

Tech giants are here to stay

Over the past few years, pharma companies have witnessed the entry and involvement of

tech companies such as Google, Apple and IBM. The latter can help collect and process massive amounts of health-related, thus helping pharma companies gain a better understanding of diseases, broaden their R&D strategies and find the right treatments.

Google’s Alphabet hosts several separate firms, including Google Ventures, Google X and Calico. All three of them are focusing on drug development. Calico tackles aging-related diseases such as Alzheimer’s, and Google Ventures increased its funding of healthcare-related ventures. Not to be left out is Google’s partnership with Novartis to develop “smart contacts” for age-related degeneration in eyesight.

Meanwhile, IBM and Apple have teamed up with Medtronic and Johnson & Johnson to carefully leverage clinical trial data to create better targeted therapies for patients, while ensuring the latter’s compliance with their drugs. Apple’s HealthKit and ResearchKit technologies are complementing such partnerships, as is IBM’s supercomputer Watson.

 

Artificial intelligence might become a game changer in the near future

Using the power of AI and supercomputers for medical decision making purposes will definitely change everyday medicine. Cognitive computing platforms such as IBM Watson have the capabilities to interact in natural language, process vast amounts of Big Data and understand patterns and insights while learning from each interaction. By digesting and interpreting millions of pages of scientific literature, IBM Watson can assist pharma companies in the development of new drugs while repurposing existing ones.

The fact that cognitive computers have been used to analyse big data, not only in genomic research but also in biotechnology, might change the way new drugs are found. The era of human experimentation might come to an end and be replaced by the era of detailed simulation of human physiology. Instead of being tested on people, drugs could be tested by supercomputers on billions of simulations modelling the physiology of the human body in a matter of seconds. This won’t happen in 2017 since it’s much too soon but it’s something that pharma should support and look into throughout the next couple of years.

These were our top picks for trends that will continue to dominate the pharma sector in 2017 and beyond. Of course, they are not set in stone. As technology advances, many great things and innovations will emerge.

 

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2017, regardless of their location. The biggest congresses next year are:

From 60 Pharma companies to 10 Big Pharma companies in 20 Years

We’ve all heard about Novartis, Pfizer, Sanofi and Roche. They’re some of the big guys in the pharma landscape, enjoying increased popularity, splitting the high budgets and revolutionizing the healthcare and pharma industry but what’s the road they took to get here? In order to answer that question, we’re going to analyze the 10 biggest pharma companies nowadays which used to be around 60 distinct companies 20 years ago. Here’s what they did to stand the test of time and grow.

best-pharmaceutical-companies

Novartis

It all dates back to 1970 when Ciba-Geigy was formed by the merger of J. R. Geigy Ltd and CIBA. In 1996, from the merger of Ciba-Geigy and Sandoz Laboratories, Novartis was born. In 2005, Novartis acquired Hexal and Eon Labs, thus growing its generic division Sandoz. A year later, in 2006, Novartis acquired full control of Chiron Corp. for USD 5.1 billion. In 2010, Novartis acquired the world’s largest eye-care company Alcon for USD 39.3 billion. Three years later, in 2012, the company bought Fougera Pharmaceuticals for USD 1.5 billion. In 2016, Novartis acquired Selexys Pharmaceuticals Corporation and SelG1 antibody for reduction of pain crises in sickle cell disease (SCD).

AstraZeneca (AZ)

AstraZeneca  was created in 1999 following the merger of Astra and Zeneca Group. In 2004, AZ completed its first big acquisition of Cambridge Antibody Technology. Later on, in 2007, it acquired MedImmune for about USD 15.2 billion. In 2012, AstraZeneca acquired Ardea Biosciences for USD 1.3 billion. One year later, it acquired Amylin from BMS for USD 4.3 billion and in 2015 acquired ZS Pharma for USD 2.7 billion. In 2015, AstraZeneca bought 55% majority stake in Acerta for USD 4 billion.

Pfizer

In 2000, Pfizer acquired American pharmaceutical company Warner–Lambert for USD 111.8 billion to bring its drug, Lipitor, to market. In 2002, Pfizer aimed to acquire full rights to Pharmacia’s product Celebrex and thus agreed to buy Pharmacia for stock valued at USD 60.0 billion. In 2009, Pfizer bought pharmaceutical company Wyeth for USD 68.0 billion. In 2015, Pfizer acquired Hospira for USD 15.2 billion and announced the merger with Allergan. The latter is considered to be one of the biggest mergers in pharma history. In 2016, Pfizer announced the successful completion of its acquisition of Medivation.

Sanofi

Sanofi resulted from the merger between Sanofi-Synthélabo and Aventis in 2004. The former was created in 1999 when Sanofi merged with Synthélabo. Aventis was formed in 1999 following the merger of Rhône-Poulenc S.A. with Hoechst Marion Roussel (HMR). The latter itself was formed in 1995 from the merger of Hoechst AG with Cassella, Roussel Uclaf and Marion Merrell Dow.

In 2011, Sanofi-Aventis acquired Genzyme and changed its name to Sanofi.

Johnson & Johnson

J&J was founded in 1886 as a medical devices, pharmaceutical and consumer packaged goods company. The pharmaceutical division is made up of Janssen & Cilag. In 2006, Janssen acquired the consumer healthcare business of Pfizer for USD 16.6 billion in what is considered to be the company’s largest M&A deals. In 2013, the company acquired Aragon Pharma and in 2014 it bought Alios BioPharma, Inc. for USD 1.75 billion.

Merck & Co.

Merck was founded in 1668 and is the world’s oldest operating chemical and pharmaceutical company. Merck & Co. was established as a subsidiary of Merck in 1891, but became an independent company in 1917. It is known as MSD (Merck Sharp and Dohme) outside of North America. In 1993, Merck purchased Medco Containment Services Inc. for USD 6 billion. In 2009, Merck merged with Schering-Plough. The latter had acquired Organon from Akzo Nobel in 2007 while Organon resulted from a merger between Diosynth and Organon in 2004. Ten years later, Merck bought Cubist Pharmaceuticals for USD 8.4 billion.

Roche

Roche’s first acquisition took place in 1994 when the company bought Syntex Corporation for USD 5.3 billion. In 2002, Roche’s Japanese subsidiary Nippon Roche merged with Chugai. Following the deal, Roche got a majority stake in the Japanese company. In 2008, Roche acquired Ventana Medical Systems for USD 3.4 billion and in 2009, the company bought Genentech for USD 46.8 billion.

Teva

Teva resulted from the merger between Assia, Zori and Teva in 1976. In 2006, Teva completed its first big acquisition of IVAX Corporation for USD 7.4 billion. In 2011, it acquired Cephalon for USD 6.8 billion. After acquiring Auspex Pharma for USD 3.5 billion in 2015, Teva completed its acquisition of Allergan’s generics business (“Actavis Generics”) in 2016.

Gilead Sciences

Gilead Sciences was founded in June 1987. Over the past 16 years, the company has made several acquisitions. The biggest ones include: CV Therapeutics for USD 1.4 billion in 2009 and USD 10.4 billion acquisition of Pharmasset in 2011.

GlaxoSmithKline (GSK)

GSK was founded in 2000 following the merger of Glaxo Wellcome and SmithKline Beecham. In 2001, GSK acquired Block Drug for USD 1.2 billion. In 2009, GSK acquired Stiefel Laboratories for USD 3.6 bn. 4 years later, in 2013, GSK acquired Human Genome Sciences (HGS) for USD 3 billion. In 2015, GSK completed the acquisition of vaccine business of Novartis and sale of its oncology business to the Swiss drug major in a global deal. Under the agreement, GSK Pharma expanded its vaccine portfolio and took over 120 employees from Novartis to boost its sales in India.

There’s so much pharma history behind all of the big names out there and the evolution is far from reaching an end. We’re looking forward to seeing what these pharma giants have in store during the next couple of years and who’s going to lead the way in the M&A sector.

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2017, regardless of their location. The biggest congresses next year are:

The European Academy for Allergy and Clinical Immunology (EAACI) Congress Barcelona in 2015

barcelona

Barcelona is one of the luckiest cities when talking about organizing Congresses. The European Academy for Allergy and Clinical Immunology has chosen Barcelona because of the enormous resources that this city can offer, both in terms of sightseeing and in terms of facilities and accommodation. For many of you, EAACI Congress Barcelona 2015 will also be a great chance for visiting the wonders of this Mediterranean Spanish city, for spending an evening on the beach and for discovering the great Spanish cuisine.

The previous experience of EAACI in organizing such events will be only in your benefit. Everything should move smooth and easy, all the seminars being held in a relaxed atmosphere. The EAACI intention is to provide the necessary tools for you to be able to create and to expose the relevant knowledge in front of an auditorium. In this way, you will gain reconnaissance and your listeners will discover the results of your researches. EAACI Congress Barcelona 2015 is offering the chance to meet new people, being those doctors, CEOs or pharmaceutical representatives. All of them are here with the sole purpose of obtaining new highly relevant information and to meet new possible partners. Everyone has the chance to discuss their problems, to express the latest clinical situation and to present the solutions they have found. Clinical cases should be discussed, while everyone will search for discovering a break-through in the field.

Participating at the EAACI Congress Barcelona 2015 is all the time a great chance for personal and professional development. The ones involved in presentations will have the chance to make themselves known, while the ones who are participating for gathering information and ideas will have the chance to increase their knowledge in the field. During the EAACI Congress Barcelona 2015, the patient will be the main target, this being strongly recommended by the congresses slogan as well: ”Allergy, new answers to old questions”